Overcoming persistent barriers to health equity in oncology trials will require innovation and cooperation.
Arturo Loaiza-Bonilla
Advertisement
Dr. Arturo Loaiza-Bonilla, MD, is the co-founder and chief medical officer of Massive Bio.
Articles by Arturo Loaiza-Bonilla
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
4
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization
5
